About 3.6 million Medicare beneficiaries could be eligible for Wegovy coverage, study shows
Injection pens and boxes of Novo
Nordisk's weight-loss drug Wegovy are shown in this photo
illustration in Oslo, Norway, November 21, 2023.
| ||||||||||||||||
| ||||||||||||||||
| ||||||||||||||||
|